Correlation Between Fate Therapeutics and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Fate Therapeutics and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Cardio Diagnostics.
Diversification Opportunities for Fate Therapeutics and Cardio Diagnostics
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fate and Cardio is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Cardio Diagnostics
Given the investment horizon of 90 days Fate Therapeutics is expected to generate 553.09 times less return on investment than Cardio Diagnostics. But when comparing it to its historical volatility, Fate Therapeutics is 16.1 times less risky than Cardio Diagnostics. It trades about 0.0 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 17.00 in Cardio Diagnostics Holdings on September 23, 2024 and sell it today you would lose (7.21) from holding Cardio Diagnostics Holdings or give up 42.41% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 86.67% |
Values | Daily Returns |
Fate Therapeutics vs. Cardio Diagnostics Holdings
Performance |
Timeline |
Fate Therapeutics |
Cardio Diagnostics |
Fate Therapeutics and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Cardio Diagnostics
The main advantage of trading using opposite Fate Therapeutics and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Cardio Diagnostics vs. Fate Therapeutics | Cardio Diagnostics vs. Sana Biotechnology | Cardio Diagnostics vs. Caribou Biosciences | Cardio Diagnostics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |